Please login to the form below

Not currently logged in
Email:
Password:

FlowMetric Diagnostics names president

Amy Williams has over 25 years of experience in life sciences

FlowMetric Diagnostics, a provider of flow cytometry and cell sorting services, has appointed Amy Williams as its president.

Williams has over 25 years of experience in the life science industry. Prior to joining FlowMetric Diagnostics, Williams was president of SageWorks Rx, a consulting company to the life science industry.

Commenting on her appointment, she said: “I am pleased and excited to be given this opportunity to lead FlowMetric Diagnostics.

“It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised medicine and better meet the needs of physicians, healthcare workers and patients.”

Williams has held a variety of commercial leadership roles at Merck and Endo Pharmaceuticals and also has expertise in marketing, sales and reimbursement. She has additionally helped launch new products and indications, creating and implementing contract reimbursement strategies.

Ren Capocasale, chairman of the board, FlowMetric Diagnostics and CEO and founder of parent company Flowmetric Inc, added: “Amy brings a wealth of experience to support our business and commercialisation initiatives and will play a pivotal role in leading and executing our business strategy now and in the years ahead.”

Williams will also join the company's board of directors.

17th December 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics